Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bayer Aktienges ADR (OP: BAYRY ) 7.810 +0.130 (+1.69%) Streaming Delayed Price Updated: 3:59 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,074,708 Open 7.700 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 7.680 Today's Range 7.700 - 7.820 52wk Range 6.820 - 13.89 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BAYRY Stock Earnings: Bayer Meets EPS, Beats Revenue for Q2 2024 August 06, 2024 BAYRY stock results show that Bayer met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer July 25, 2024 Australian judge dismisses class action lawsuit against Bayer for Roundup causing cancer. Ruling supports company's stance that product is safe. Via Benzinga Topics Lawsuit Exposures Financial Glyphosate Legal Performance YTD -16.74% -16.74% 1 Month +7.13% +7.13% 3 Month +3.63% +3.63% 6 Month +0.64% +0.64% 1 Year -41.98% -41.98% More News Read More ScottsMiracle-Gro Stock Blooms After Investor Day Optimism July 23, 2024 Via MarketBeat Topics Cannabis Exposures Cannabis 3 Longevity Stocks to Buy for Anti-Aging Breakthroughs July 08, 2024 Via InvestorPlace 3 Small-Cap Stocks With Explosive 2X Growth Potential July 08, 2024 Via InvestorPlace Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M June 05, 2024 Via Benzinga Exposures Glyphosate Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership June 01, 2024 Via Talk Markets European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday? May 27, 2024 Via Benzinga After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February May 24, 2024 Via Benzinga Topics Data Breach Exposures Information Security Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval May 17, 2024 Via Benzinga Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game May 16, 2024 Via Benzinga BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q1 2024 May 14, 2024 Via InvestorPlace From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch May 10, 2024 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned May 02, 2024 Via Benzinga Exposures Glyphosate Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades' April 10, 2024 Via Benzinga Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists April 09, 2024 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds April 05, 2024 Via Benzinga Topics Bonds Exposures Debt Markets Bayer-Backed Boundless Bio Falls After IPO March 31, 2024 Via Talk Markets Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms March 19, 2024 Via AB Newswire Topics Supply Chain Exposures Supply Chain Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant March 19, 2024 Via Benzinga Exposures Product Safety German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits March 14, 2024 Via Benzinga Topics Bankruptcy Lawsuit Exposures Financial Glyphosate Legal BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q4 2023 March 05, 2024 Via InvestorPlace Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges March 05, 2024 Via Benzinga Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits March 04, 2024 Via InvestorPlace What's Going On With BridgeBio Pharma Stock On Monday? March 04, 2024 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.